BillionToOne is a pioneering brand at the forefront of disease detection, with a mission to move Prenatal Screening and Liquid Biopsy forward. Their revolutionary technology allows for the detection and quantification of disease at a single base-pair resolution, offering a breakthrough in disease detection. BillionToOne's proprietary Quantitative Counting Templates, or QCTs™, empower them to detect and measure tiny and sparse disease-related DNA fragments with incredible accuracy.

This opens the door to exponential improvements in prenatal screening and liquid biopsy. In terms of products, BillionToOne offers cutting-edge solutions in both Oncology and Prenatal screening. In Oncology, their Northstar Select™ and Northstar Response™ products help determine the most effective first-line therapy and monitor its effectiveness.

For Prenatal screening, their UNITY Screen™ offers a comprehensive assessment of fetal risk for recessive conditions and aneuploidies using just a maternal blood draw. Paternal samples are not required. BillionToOne's success is spurred on by their incredibly talented and passionate team, all driven by the goal of making molecular testing more accurate, efficient, and accessible for all.

With a strong culture of growth, equality, and cross-departmental teamwork, they are improving healthcare and seeking like-minded individuals to join their mission